Nina Rognon

"What's new in healthcare innovation globally?" I had the pleasure to share my thoughts on this topic at the annual event in Paris hosted by La Poste Santé & Autonomie, which brought together the entire French #healthcare and #healthTech ecosystem. Thank you florence dupre and Olivier Barets for the invitation, and appreciation to my fellow panelists: . François BRAUN: Former Minister of Social Affairs and Health of #France . stephane pierrefitte: Deputy General Director at the University Hospital Group (Psychiatry & Neurosciences) . Hélène GUIMIOT: Head of the Health Service in the Legal Support Department of the French data protection authority (CNIL) . Kathy Malas: Director of Research, Innovation, and Learning at CISSS Montérégie-Ouest, Quebec. Special thanks to Dominique Pon, CEO of La Poste Santé & Autonomie for the great moderation (and great event). The key points of my presentations in a nutshell: The NHS, a cornerstone of British pride, is in crisis according to Lord Darzi's 2024 report (published in Sep 24) Key findings show 33% of Britons now wait over a week for GP appointments, compared to 16% in 2021. Bupa has responded by offering a subscription model for primary care: £17/month for same-day teleconsultations or £22/month for in-person visits, raising concerns about a potential two-tier system. Following the publication of the report, UK Prime Minister Sir Keir Starmer aims to transition the NHS to a digital system. There are already promising initiatives within the NHS like the 42 Integrated Care Systems (ICS) and the GP Practice Improvement Program, which has replaced 30% of face-to-face visits with text consultations. AI could also play a crucial role, with most NHS staff supporting its use in patient care (76%) and administration (81%). Four key #AI archetypes include: 1️⃣ Non-clinical AI for consumers/patients AI-based care navigation, seen with US companies like Transcarent or UnitedHealth Group's Find Care & Costs tool. 2️⃣ Clinical AI for consumers/patients AI predictive models intercepting disease through blood analysis (e.g., Function Health, Aware) or imaging (e.g., Neko Health). 3️⃣ Clinical AI for health professionals AI Clinical Decision Support (AI-CDS), especially in radiology (75% of FDA approved AI-CDS), but also beyond with companies like Tempus AI in AI-oncology. 4️⃣ Non-clinical AI for healthcare professionals AI-enhanced administrative management (like Ambient AI, ...), likely to see the fastest adoption in the short term. Three potential winners in the AI healthcare transformation: Epic: Aiming to orchestrate AI in hospitals with its App Store Showroom. Mayo Clinic: Already using 70+ AI algorithms and developing the Mayo Clinic Platform_Connect, a data hub connecting major hospitals for AI model training. La Poste Santé & Autonomie: An innovative public player acting as a trusted intermediary between healthcare systems, industry, and regulators to implement new models of care.

147

7 commentaires

Looking forward to speaking at HLTH Europe tomorrow - the first European edition of the #1 healthcare event in the US! Along with 3 impressive panellists from the NHS, Doctolib and doctorly, as well as our moderator from Capgemini, we will discuss "rewriting the script" for Electronic Health Records. Join us tomorrow at 9:50 on the Aroma stage https://lnkd.in/dAj27pZg "Come on down and jump into the HLTH Europe time machine, as we head back to 1968. Humans are yet to set foot on the moon. The Beatles’ Hey Jude has just done a record nine weeks on the top of the charts. Charles de Gaulle is coming to the end of 10 years in power. Oh, and the first EHR has launched. Those first punch cards spawned an industry worth $28 billion today. We may have switched gears from the old problem-oriented records to subjective, objective, assessment, and plan (SOAP) notes, but even as the industry trundles along, the complete potential of EHRs remains a mystery for medical professionals, patients, and health systems. With more data available than ever before, functionality requests coming in faster than the industry can process, and ever-increasing demand on systems often built decades ago, how do we set the EHR straight?" #hlth #hltheurope #ehr #ai #healthcare Autoscriber LUMO Labs Brabantse Ontwikkelings Maatschappij (BOM)

54

🧑‍⚕️ 'Our home #nurses exchange information about #patients and make mutual decisions via Doctolib Siilo. It is crucial that they can communicate with each other securely, especially as we handle sensitive information subject to #GDPR legislation', says Julie Vanhoof, Business Unit Manager at OptiCare Thuisverpleging. Read the full interview with Julie about the use of Doctolib Siilo within their organisation (article in Dutch 🇳🇱🇧🇪) >> https://ow.ly/gwIL50RQyoJ #healthcare #ehealth #medicine #gezondheidszorg #zorg

19

3 commentaires

'Healthcare platform Doctolib has conquered France — but can it take on Europe?' Lloyd Price, HealthTech M&A Advisor and Partner at Nelson Advisors shares his thoughts with Daphné Leprince-Ringuet from Sifted discussing Doctolib, their continued success, big future and potential next moves. 'Few startups in France can claim to have changed the way people behave in as systemic a way as Doctolib. Launched in 2013 by Stanislas Niox-Chateau, Doctolib has become a key component of the country’s healthcare system. Its first product — an online booking platform that lets patients schedule doctor appointments — saw huge adoption in a sector with very little digitisation. > Today, the company covers “almost all of the French population”, says Doctolib’s CFO Pierre Vergnes. It counts 80m patient accounts spanning three countries, of which the vast majority remains in France. Doctolib also has 19m users in Germany, which it expanded to in 2016, and a “nascent” number of users in Italy, launched in 2021. > During the Covid pandemic, the French government selected the company as an official partner to manage vaccination appointments. “[In France], they’re a utility company for running healthcare infrastructure now,” says Lloyd Price, a healthtech M&A advisor. Mergers, Acquisitions, Growth and Strategy for Healthcare Technology companies > HealthTech M&A - Buy Side, Sell Side, Growth & Strategy services for companies in Europe, Middle East and Africa. Visit www.nelsonadvisors.co.uk > HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, Digital Health Insights and Analysis. Subscribe Today! https://lnkd.in/e5hTp_xb > Healthcare Technology Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Email [email protected] > Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Visit https://lnkd.in/ezyUh5i https://lnkd.in/edDCqmrz

1

1 commentaire

how brillant! At #OrphanHealthcare, we've just kicked open the doors to an new opportunity that's as big as the free pizza at a startup launch! We’re getting a new office at the end of summer and offering a great, still free 120 sqm of ultra-modern office space for your, absolutely amazing! And trust me, this isn't your average, everyday office space at the edge of Zurich. It combines work and work-life balance. 😍 Here’s the Scoop on the Space: 🖐🏻 If size Matters: A whopping 350 sqm of chic, open-plan office space begging you to throw some desks and dreams into it. And 120 sqm are still available for you. 🛀🏻 Design & Comfort: It’s got everything – 2 snazzy meeting rooms for when you need to impress, a lounge for lounging (obviously), an open kitchen to test your cooking show fantasies, and even an event spot for your TEDx rehearsal. 🤓 Tech Ready: All the state-of-the-art fixings to make sure you can tweet faster, work smarter, and Netflix chill harder. ⛳ Location, Location, Location: Right on the nerve center of everything cool - next to trams, trains, and an expressway to pretty much everywhere. 🚀 Why You’ll Love It: Price Tag. It’s about amazing for the prices others pay in downtown Zurich. Flex Appeal. Mold it, shape it, and dance in it – make this space your own! Network Nirvana. Join a community of thinkers, leaders, and occasional coffee-sharing who are all on the path to greatness. 👥 Limited Edition! This isn’t a drill people, spaces like this don’t come by often and they don’t stay free for long. It’s time to level up your workplace vibe and get your team into something stellar. And 2 wonderful partners are on board: Q4BS GmbH and The Social Mall - Center for Social Quality Impact 📞 Ready to claim your space in our new corporate paradise? Hit us up at [email protected] and let’s chat about making magic happen in our new office! #Sustainable #Campus! 🎈 #OfficeSpace #Workspace #ModernOffice #BusinessOpportunity #OfficeForRent #ProfessionalSpace #CollaborationSpace

3

2 commentaires

Looking forward to sharing my perspectives and hearing how others are approaching the global VC landscape at this session at #GRIC2024!

19

Thank you again #Nobel Prize Laureate Jean Tirole & Pierre Dubois for a thought-provoking Health Economics Conference at Toulouse School of Economics last month! ❣ Happy to share that the replay 📹 of our panel on the use of Health Data, Platforms & Digital Technologies for Innovation is now available 👇 The panel was chaired by Jean Tirole, with Edwin Morley-Fletcher & Ariel Dora Stern 👉 I was happy to present Dassault Systèmes' ambition in #LifeSciences & #Healthcare, and how #VirtualTwin can accelerate therapeutic innovation and improve medical practice. Among examples shared, I mentioned #SCA (synthetic control arms), #MediTwin, our partnership with FDA for in silico clinical trials. Edwin Morley-Fletcher shared the ambition of European Commission to build a common platform for Human Virtual Twins and the role played by #EDITH consortium to create standards. Ariel Dora Stern shared meaningful examples of the use of #AI and #GenAI in drug discovery as well as medical practice. The ⁉ Q&A ⁉ session was quite stimulating, thank you 🙏 to the passionate attendees in the audience! 🌩 Key challenges ahead of us include: 1️⃣ Access to data, which itself requires a solid business model, data standardization, trusted Cloud 2️⃣ Reimbursement & adoption in physicians workflow -> change management will be key

27

A huge milestone for Lifen! 🧬 👏 The HealthTech startup is investing €15 million in research & development thanks to #France2030. 🎯As winners of the I-Démo call for projects, Lifen will be backed by France 2030 and will accelerate the development of Lifen DataLab, using AI to collect and structure real-life patient data. This initiative will create high-quality databases across various therapeutic areas, both improving patient care and solidifying France’s status as a leader in digital health. 🤖 As accessing and structuring health data becomes more complex, Lifen DataLab aims to combat this time-consuming and expensive process. To do this, they plan to exploit the potential of the latest developments in AI to generate exceptional databases, ultimately improving clinical research and patient care. Want to find out more? Head to the comments to read the official press release (in French) 👇 CC Franck Le Ouay, Alexandre Huckert, Etienne Depaulis Jean-Marc Patouillaud

74

3 commentaires

Curious about the intersection of health innovation and venture capital? Don’t miss this episode featuring Anne-Sophie Saint-Martin, Partner at Newfund, as she shares her journey and insights on investing in health startups and launching a fund dedicated to brain startups. In this podcast, you’ll discover: ✅ Anne-Sophie’s unique background and what drives her passion for health investments. ✅ Why health tech is a unique and complex investment field, often overlooked for this very reason, yet incredibly compelling both for its societal impact and its financial performance potential. ✅ How this focus perfectly aligns with Newfund’s mission of bridging Europe and the U.S. since its launch in 2008. Newfund continues to champion bold ideas and international synergies across markets. Tune in to learn how we’re shaping the future of health and innovation on both sides of the Atlantic! 🌎✨ 🎧 Listen now: https://lnkd.in/ei_2ZY2E Thx Benjamin WATTINNE for this great podcast series! #VentureCapital #HealthTech #BrainHealth #Innovation #Startups #Europe #USA #HekaFund

34

2 commentaires

At Beo Healthcare, we partner with multiple health professionals to ensure that #alix, our hybrid artificial intelligence, includes the right features and benefit for patients' quality of life. Alix is designed to target multiple diseases, including #cancer We want to thank MD, brain surgeons at CHU de Brest for sharing relevant research publications with us to allow the right developments of Alix, in particular to have a solution that is customized, specific to each individual Extracts from the Abstract ⤵️: " Fatigue is one of the most common adverse effects of cancer that might persist for years after treatment completion in otherwise healthy survivors. Cancer-related fatigue causes disruption in all aspects of quality of life and might be a risk factor of reduced survival. The prevalence and course of fatigue in patients with cancer have been well characterized and there is growing understanding of the underlying biological mechanisms. Inflammation seems to have a key role in fatigue before, during, and after cancer-treatment. However, there is a considerable variability in the presentation of cancer-related fatigue, much of which is not explained by disease-related or treatment-related characteristics" "... a variety of intervention approaches have shown beneficial effects in randomized controlled trials, including physical activity, psychosocial, mind–body, and pharmacological treatments..." #md #hospital #cancer #AI #AIforHealth #Healthcare #Europe #USA #futureofmedicine #physicalactivity #customizedmedecine #patientqualityoflife #brainsurgeon #fatigue #cancerrelatedfatigue Sophie Deniel Yannick GUILLODO Chloé Le Douarin Sullivan Gauville Lucas Morisseau Maxime B'chir Benoît Quero Jean-Luc DUFOUR Mathieu Champenois Yann Le DOUARIN Nature Research Custom Media UCLA MACMILLAN PUBLISHERS INTERNATIONAL LIMITED

8

Are French unicorns ready for their IPO? I'll say yes, and probably even a bit better than German startups! Let me tell you why. Most IPOs are driven by the CEO / CFO couple but there is a third important wheel to this constellation: the CMO! A big part of a successful IPO and then stock exchange valuation is communication. It's all about trust, baby! And trust is built through communication & thought leadership. French startups are often very strong in being transparent and proactive in their communications. So this is a solid basis to work on. Here are my learnings from working on KATEK GROUP's IPO: ‣ It's not all about the press: Yes, mandatory investor relations (IR) news have to be communicated through the press. By going further and also using your company's owned channels you show even more transparency to your stakeholders. Communicating on LinkedIn will enable dialog with your investors. ‣ IR does not need to be boring: Financial reports might not sound as sexy as the next big brand campaign, but it can be. Use videos to explain the numbers further, plan live Q&A sessions with the CEO. Be creative and stay true to your brand's values. ‣ It's about the people: The stock exchange market is a numbers and money world. By involving your C-level in the communication you will be able to build up a stronger trust in your company. In people we trust! Here think about news hijacking to position your C-level as the experts they are, do video interviews or quote statements. You can read more about KATEK's IPO and strategic communication here: https://lnkd.in/dFYscP3k #IPO #ListedInFrankfurt #FrenchTech #StartupCommunication

3

Innovating in life sciences? Join the webinar!

3

By what means can we describe the universe, at the level of the infinitely small and the infinitely large including the 4 fundamental forces that govern the universe 🤔 ? 📗The answer is simple thanks to the infinitesimal unit wave vector of the released photon as described in kenitic theory by Dr. Feynman ( رحمه الله) in chapter 39_3 of compressibility of radiation ✍🏼.

1

5 commentaires

AI for Health 🤖 👨‍⚕️ If you are curious about the impact of AI on healthcare, let's meet today at STATION F for AI for Health ! I'll be happy to discuss the wins and hurdles of AI in cardiology care journeys through our learnings at Noctua Care 🫀🦉 #AIforHealth #AIforHealthSummit #cardiology #AI

43

Digital Health in France: A Snapshot Over a year after #telemonitoring was officially integrated into France's healthcare system, the digital health market is beginning to take shape. While telemonitoring is making headway, particularly in oncology, digital therapies (#DTx) are struggling to gain a foothold. ✅ Telemonitoring Leading the Way, DTx Lagging Behind France has made notable progress in telemonitoring, with systems like Resilience Pro seeing success, especially in oncology. However, DTx is still facing significant challenges. The sluggish pace is primarily due to stringent requirements for clinical and organizational benefits, coupled with the government’s public health priorities, which tend to favour oncology and mental health (like depression and anxiety) while leaving areas like rehabilitation and chronic disease management behind. ✅ Market Trends: Where Digital Health is Gaining Ground ✔ Telemonitoring Gains Momentum in Oncology: Since June 2023, telemonitoring devices have been reimbursed under the general health coverage system, with cancer monitoring tools showing strong progress (1890 health structures have declared a remote monitoring activity so far). ✔ DTx Adoption Slow: Despite the rise of digital therapies in Europe, France lags behind countries like Germany. Hannes Klöpper has recently posted valuable insight about HelloBetter's struggle to secure reimbursement from Cnedimts. ✅ France vs. Germany France’s strict regulatory landscape contrasts sharply with Germany’s more flexible DiGA program, which allows faster reimbursement for digital health applications. Germany’s approach has fostered a broad range of innovative solutions, while France’s focus remains on specific areas like oncology. This explains why Germany is ahead in DTx adoption. ✅ Navigating the French Market: Key Insights and some advise ✔ Tackle Regulatory Hurdles Head-On: Be ready for a rigorous approval process, particularly for DTx. Early engagement with French authorities and collaboration with local players will definitely help navigate this complex landscape. I would recommend an upfront check-up of your « Market Access Readiness ». Spending that time is gaining a better view on your winning strategy and evaluating your chances more efficiently. ✔ Align with Priority Areas: Products targeting government-prioritized areas like oncology and mental health are more likely to succeed. Keep an eye on evolving health priorities to position your offerings strategically. ✔ Leverage Partnerships and Pilots: Forge alliances with influent French stakeholders and participate in pilot projects like “Article 51” to enhance market entry and boost approval chances. ✔ Plan for Financial Challenges: The path to market in France is costly and time-consuming. Explore alternative business models, such as direct-to-patient sales or partnerships with private insurers, to offset upfront costs.

2

Doctolib is looking for a match. 💙 Health is likely the sector that will benefit the most from the current AI advancements. At Doctolib, AI has opened up new possibilities for us to realize the dreams we’ve shared with healthcare professionals since day one. In this context, AI is being seamlessly integrated into most of our products for patients and healthcare providers to make them more relevant, efficient and to better meet their needs. AI will allow us to launch new products that were previously unimaginable pushing the boundaries of what is possible in healthcare. While we've made great strides with our team notably with the help of Typeless and Aaron.ai, we know that to achieve these ambitions, we need to go even further, and that’s why we are seeking new innovative AI partners in healthcare – and this could be you, or someone you know! From day one, our purpose at Doctolib has been simple : we improve the daily life of health professionals and we help people to be healthier. While we've already made an impact, I’m more convinced than ever that artificial intelligence is essential to fully realizing this vision and to help healthcare professionals spend much less time being data archaeologists. That's why we're actively looking to work with… ✨ 𝗔𝗜 𝘁𝗲𝗮𝗺𝘀 𝘄𝗵𝗼 𝘀𝗵𝗮𝗿𝗲 𝗼𝘂𝗿 𝘃𝗶𝘀𝗶𝗼𝗻 𝗮𝗻𝗱 𝗽𝗮𝘀𝘀𝗶𝗼𝗻 𝗳𝗼𝗿 𝗵𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲 𝗶𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻. ✨ We’re particularly interested in: 🔹 𝗔𝗜 𝘀𝘁𝗮𝗿𝘁-𝘂𝗽𝘀 𝗯𝗮𝘀𝗲𝗱 𝗶𝗻 𝗘𝘂𝗿𝗼𝗽𝗲. 🔹 Expert teams specializing in 𝗟𝗮𝗿𝗴𝗲 𝗟𝗮𝗻𝗴𝘂𝗮𝗴𝗲 𝗠𝗼𝗱𝗲𝗹𝘀 (𝗟𝗟𝗠𝘀), whether fine-tuning, model orchestration, or multimodal applications. Expertise in healthcare or generalist AI is welcomed. 🔹 𝗡𝗟𝗣 𝗮𝗻𝗱 𝗠𝗟 𝘀𝗽𝗲𝗰𝗶𝗮𝗹𝗶𝘀𝘁𝘀 who can help develop future AI-native products. If this sounds like you or someone you know, feel free to reach out at [email protected], we’d love to connect and explore how we can work together to create something impactful. I’m convinced that, together, we can build the healthcare we all dream of.

2 441

262 commentaires

Facing growing challenges like staff shortages, medication complexity, and the need for better care coordination, AI emerges as a promising solution. A recent study by Health&Tech Intelligence shows that In-House Pharmacies (PUIs) in France are at the forefront of AI adoption, developing innovative tools to address their specific service needs. #AI #artificialintelligence #healthcareAI #AIinhealthcare #hospitalpharmacy #patientsafety #HealthTechIntelligence #pharmaciehospitalière

3

How Doctolib is Transforming Healthcare, One Appointment at a Time Let's keep it simple to understand Once upon a time in the world(before COVID I can say) of healthcare, patients were struggling to book appointments, and doctors were drowning in missed calls and cluttered schedules. Then came Doctolib, a startup that launched in 2013 with a simple goal: to make healthcare easier for everyone. Fast forward to 2024, and Doctolib has grown into a powerful platform. They send out 93 million reminders every month to help patients remember their appointments. Because,remembering dates is not everyone’s strong suit! This year, they invested €92 million to improve their services, making it even easier for patients to connect with doctors and access care. They even added video consultations and tools that help predict when patients might actually show up, maybe teleportation is next. As I observe Doctolib’s journey, I realize the importance of innovation in solving real problems. P.S.:I’m on the lookout for a summer internship. If anyone needs a Product Manager who brings a fresh perspective (and a bit of humor), I’m your person! #Doctolib #ProductManagement #Healthcare #Audencia #LookingForInternship

10